학술논문

Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples
Document Type
article
Source
PLOS ONE. 16(8)
Subject
Clinical Research
Biotechnology
Prevention
Genetics
Emerging Infectious Diseases
Infectious Diseases
4.2 Evaluation of markers and technologies
Detection
screening and diagnosis
Infection
Good Health and Well Being
Adult
COVID-19
COVID-19 Testing
Female
Humans
Male
Mass Screening
RNA
RNA
Viral
Real-Time Polymerase Chain Reaction
Robotics
SARS-CoV-2
Saliva
Specimen Handling
IGI SARS-CoV-2 Consortium
General Science & Technology
Language
Abstract
Saliva is an attractive specimen type for asymptomatic surveillance of COVID-19 in large populations due to its ease of collection and its demonstrated utility for detecting RNA from SARS-CoV-2. Multiple saliva-based viral detection protocols use a direct-to-RT-qPCR approach that eliminates nucleic acid extraction but can reduce viral RNA detection sensitivity. To improve test sensitivity while maintaining speed, we developed a robotic nucleic acid extraction method for detecting SARS-CoV-2 RNA in saliva samples with high throughput. Using this assay, the Free Asymptomatic Saliva Testing (IGI FAST) research study on the UC Berkeley campus conducted 11,971 tests on supervised self-collected saliva samples and identified rare positive specimens containing SARS-CoV-2 RNA during a time of low infection prevalence. In an attempt to increase testing capacity, we further adapted our robotic extraction assay to process pooled saliva samples. We also benchmarked our assay against nasopharyngeal swab specimens and found saliva methods require further optimization to match this gold standard. Finally, we designed and validated a RT-qPCR test suitable for saliva self-collection. These results establish a robotic extraction-based procedure for rapid PCR-based saliva testing that is suitable for samples from both symptomatic and asymptomatic individuals.